Toggle Main Menu Toggle Search

Open Access padlockePrints

Suppressing tumourigenicity of prostate cancer cells by inhibiting osteopontin expression

Lookup NU author(s): Dr Imad Malki

Downloads


Abstract

Expression of osteopontin (OPN) is increased in prostate cancer cells. The possibility of utilising the increased OPN as a target to suppress the tumourigenicity was investigated in this study. Small interference RNAs against OPN were transfected into highly malignant DU145 prostate cancer cells, which express high level of OPN prior to the transfections, to establish OPN-suppressed clones. Compared with the control transfectants generated by scrambled RNA, suppressed expression of OPN significantly inhibited cell invasiveness and anchorage-independent growth. Similar results were obtained from in vivo experiments. OPN-suppressed transfectants produced significant reductions in average sizes of subcutaneous tumours after inoculation into nude mice. When the levels of OPN measured in transfectants before injection were related to tumour sizes, the reduction in tumour sizes was not propotionally related to the inhibition in OPN-levels. However, when the levels of OPN were analysed in the tumour tissues, it was found that the reduced OPN expression levels were significantly associated with the reducing tumour sizes. These results showed that changes in OPN levels had occurred after the transfectants were inoculated in mice. This study suggested while OPN can be an effective target for therapeutic suppression of prostate cancer, more effective way than RNAi is needed to inhibit OPN expression.


Publication metadata

Author(s): Zhang Y, Forootan SS, Kamalian L, Bao ZZ, Malki MI, Foster CS, Ke Y

Publication type: Article

Publication status: Published

Journal: International Journal of Oncology

Year: 2011

Volume: 38

Issue: 4

Pages: 1083-1091

Print publication date: 02/02/2011

Date deposited: 23/04/2013

ISSN (print): 1019-6439

ISSN (electronic): 1791-2423

Publisher: Spandidos Publications

URL: http://dx.doi.org/10.3892/ijo.2011.932

DOI: 10.3892/ijo.2011.932

PubMed id: 21290088


Altmetrics

Altmetrics provided by Altmetric


Actions

Find at Newcastle University icon    Link to this publication


Share